Overview |
bsm-33112M-PE-Cy7 |
CD41/Integrin alpha 2b Monoclonal Antibody, PE-Cy7 Conjugated |
WB |
Human |
Specifications |
PE-Cy7 |
Mouse |
KLH conjugated synthetic peptide derived from human CD41/Integrin alpha 2b |
Monoclonal |
9B10 |
IgG |
1ug/ul |
Purified by Protein G. |
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Store at -20¡C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
3674 |
P08514 |
platelet glycoprotein IIb of IIb/IIIa complex; Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41); ITGA2B; GPIIb; GTA; HPA3; CD 41; CD41; CD41 antigen; CD41a; CD41b; GP2b; GPalpha IIb; GPalphaIIb; Integrin alpha IIb; Integrin alpha IIb precursor; ITGA 2B; ITGA2B; ITGAB; Platelet fibrinogen receptor alpha; Platelet fibrinogen receptor alpha subunit; Platelet glycoprotein IIb of IIb/IIIa complex; Platelet membrane glycoprotein IIb; Platelet specific antigen bak; ITA2B_HUMAN. |
Isoform 1 and isoform 2 were identified in platelets and megakaryocytes, but not in reticulocytes or in Jurkat and U937 white blood cell line. Isoform 3 is expressed by leukemia, prostate adenocarcinoma and melanoma cells but not by platelets or normal prostate or breast epithelial cells. |
Application Dilution |
WB |
1:300-5000 |